Diabetes and its Complications - Contemporary Treatment and Potential Side Effects of Drugs to Treat Diabetes

Author(s): Peter Vestergaard*

Journal Name: Current Drug Safety

Volume 16 , Issue 1 , 2021


Become EABM
Become Reviewer
Call for Editor

[1]
Rasmussen NH, Dal J, den Bergh JV, de Vries F, Jensen MH, Vestergaard P. Increased risk of falls, fall-related injuries and fractures in people with type 1 and type 2 diabetes - a nationwide cohort study. Curr Drug Saf 2021; 6(1): 52-61.
[http://dx.doi.org/10.2174/1574886315666200908110058] [PMID: 32900349]
[2]
Nissen TPH, Vorum H, Aasbjerg K. Biologic therapy and treatment options in diabetic retinopathy with diabetic macular edema. Curr Drug Saf 2021; 6(1): 17-31.
[http://dx.doi.org/0.2174/1574886315666200902154322] [PMID: 32881673]
[3]
Røikjer J, Mørch CD, Ejskjaer N. Diabetic peripheral neuropathy: Diagnosis and treatment. Curr Drug Saf 2021; 6(1): 2-16.
[http://dx.doi.org/10.2174/1574886315666200731173113] [PMID: 32735526]
[4]
Pietraszek A. Cardiovascular Effects of hypoglycemic agents in diabetes mellitus. Curr Drug Saf 2021; 6(1): 32-51.
[http://dx.doi.org/10.2174/1574886315666200902154736] [PMID: 32881674]
[5]
Laursen HVB, Røikjer JB, Dal J, Jensen MH. Sodium glucose cotransporter-2 inhibitor treatment and the risk of diabetic ketoacidosis in Denmark: A retrospective cohort study of five years of use. Curr Drug Saf 2021; 6(1): 73-81.
[http://dx.doi.org/10.2174/1574886315666200819114629] [PMID: 32814538]
[6]
Werkman NCC, Nielen JTH, van den Bergh JPW, et al. Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and risk of lower limb amputation. Curr Drug Saf 2021; 6(1): 62-72.
[http://dx.doi.org/10.2174/1574886315666200805103053] [PMID: 32767909]


free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 1
Year: 2021
Published on: 02 February, 2021
Page: [1 - 1]
Pages: 1
DOI: 10.2174/157488631601210203093615

Article Metrics

PDF: 17
HTML: 1